β-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937)

Effects of cations and guanosine triphosphate

Nahid A. Shahabi, Phillip K. Peterson, Burt Sharp

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Some of the functional effects of β-endorphin on immune cells are resistant to inhibition by naloxone. To further characterize the β-[125I]endorphin-binding site mediating these effects and its response to cations and GTP, the human monocyte-like cell line U937 was used. Incubation of intact cells and -β-[125I]endorphin for 60 min at 4 C demonstrated a saturable, high affinity binding site [Kd = 1.2 ± 0.5 x 10-8 M (mean ± SE; n = 4] competed by equimolar β-endorphin and N-acetyl (Ac)-β-endorphin but not by naloxone, morphine, or selective opiate receptor agonists. Competition studies showed that β-endorphin-(6-31) and β-endorphin-(28-31) were approximately 5-and 100fold less potent, respectively, whereas β-endorphin-(l-16) or -(1-27) was ineffective. Covalent cross-linking of β-[125I]endorphin to intact cells and resolution by gel electrophoresis showed dominant bands at 59K and 44K and a minor band at 66K. The bands at 44K and 66K were completely displaced by increasing equivalent concentrations of β-endorphin and N-Ac-β-endor-phin. Increasing concentrations of mono (Na+K+)-and divalent (Ca2+Mg2+Mn2+) cations reduced the binding of β-[125I]endorphin to U937 membrane; β-[125I] endorphin binding to rat brain membrane showed similar cation sensitivity. GTP7-sulfate (GTPγS; 10-4 M) alone reduced binding to U937 membrane by 25%. In the presence of Na+ (100 or 150 mM) or Mg2+ (10 mM), GTP γS reduced binding by an additional 50%. Moreover, GTP γS (10-8-10-4 M) in the presence of Na+ (100 mM) reduced binding in a dose-dependent manner, whereas GMP was ineffective. In conclusion, β-endorphin binds to sites on human U937 cells similar to those observed on normal murine spleno-cytes. Although naloxone insensitive, these sites exhibit properties, such as size, salt sensitivity, and coupling to a GTP-binding protein, that are similar to those observed for agonist binding to brain opiate receptors.

Original languageEnglish (US)
Pages (from-to)3006-3015
Number of pages10
JournalEndocrinology
Volume126
Issue number6
DOIs
StatePublished - Jan 1 1990

Fingerprint

Endorphins
Naloxone
Guanosine Triphosphate
Cations
Cell Line
Opioid Receptors
Membranes
Binding Sites
U937 Cells
Brain
GTP-Binding Proteins
Morphine
Sulfates

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

β-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937) : Effects of cations and guanosine triphosphate. / Shahabi, Nahid A.; Peterson, Phillip K.; Sharp, Burt.

In: Endocrinology, Vol. 126, No. 6, 01.01.1990, p. 3006-3015.

Research output: Contribution to journalArticle

@article{de9eacfd39eb4272978817f10ae2a585,
title = "β-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): Effects of cations and guanosine triphosphate",
abstract = "Some of the functional effects of β-endorphin on immune cells are resistant to inhibition by naloxone. To further characterize the β-[125I]endorphin-binding site mediating these effects and its response to cations and GTP, the human monocyte-like cell line U937 was used. Incubation of intact cells and -β-[125I]endorphin for 60 min at 4 C demonstrated a saturable, high affinity binding site [Kd = 1.2 ± 0.5 x 10-8 M (mean ± SE; n = 4] competed by equimolar β-endorphin and N-acetyl (Ac)-β-endorphin but not by naloxone, morphine, or selective opiate receptor agonists. Competition studies showed that β-endorphin-(6-31) and β-endorphin-(28-31) were approximately 5-and 100fold less potent, respectively, whereas β-endorphin-(l-16) or -(1-27) was ineffective. Covalent cross-linking of β-[125I]endorphin to intact cells and resolution by gel electrophoresis showed dominant bands at 59K and 44K and a minor band at 66K. The bands at 44K and 66K were completely displaced by increasing equivalent concentrations of β-endorphin and N-Ac-β-endor-phin. Increasing concentrations of mono (Na+K+)-and divalent (Ca2+Mg2+Mn2+) cations reduced the binding of β-[125I]endorphin to U937 membrane; β-[125I] endorphin binding to rat brain membrane showed similar cation sensitivity. GTP7-sulfate (GTPγS; 10-4 M) alone reduced binding to U937 membrane by 25{\%}. In the presence of Na+ (100 or 150 mM) or Mg2+ (10 mM), GTP γS reduced binding by an additional 50{\%}. Moreover, GTP γS (10-8-10-4 M) in the presence of Na+ (100 mM) reduced binding in a dose-dependent manner, whereas GMP was ineffective. In conclusion, β-endorphin binds to sites on human U937 cells similar to those observed on normal murine spleno-cytes. Although naloxone insensitive, these sites exhibit properties, such as size, salt sensitivity, and coupling to a GTP-binding protein, that are similar to those observed for agonist binding to brain opiate receptors.",
author = "Shahabi, {Nahid A.} and Peterson, {Phillip K.} and Burt Sharp",
year = "1990",
month = "1",
day = "1",
doi = "10.1210/endo-126-6-3006",
language = "English (US)",
volume = "126",
pages = "3006--3015",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - β-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937)

T2 - Effects of cations and guanosine triphosphate

AU - Shahabi, Nahid A.

AU - Peterson, Phillip K.

AU - Sharp, Burt

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Some of the functional effects of β-endorphin on immune cells are resistant to inhibition by naloxone. To further characterize the β-[125I]endorphin-binding site mediating these effects and its response to cations and GTP, the human monocyte-like cell line U937 was used. Incubation of intact cells and -β-[125I]endorphin for 60 min at 4 C demonstrated a saturable, high affinity binding site [Kd = 1.2 ± 0.5 x 10-8 M (mean ± SE; n = 4] competed by equimolar β-endorphin and N-acetyl (Ac)-β-endorphin but not by naloxone, morphine, or selective opiate receptor agonists. Competition studies showed that β-endorphin-(6-31) and β-endorphin-(28-31) were approximately 5-and 100fold less potent, respectively, whereas β-endorphin-(l-16) or -(1-27) was ineffective. Covalent cross-linking of β-[125I]endorphin to intact cells and resolution by gel electrophoresis showed dominant bands at 59K and 44K and a minor band at 66K. The bands at 44K and 66K were completely displaced by increasing equivalent concentrations of β-endorphin and N-Ac-β-endor-phin. Increasing concentrations of mono (Na+K+)-and divalent (Ca2+Mg2+Mn2+) cations reduced the binding of β-[125I]endorphin to U937 membrane; β-[125I] endorphin binding to rat brain membrane showed similar cation sensitivity. GTP7-sulfate (GTPγS; 10-4 M) alone reduced binding to U937 membrane by 25%. In the presence of Na+ (100 or 150 mM) or Mg2+ (10 mM), GTP γS reduced binding by an additional 50%. Moreover, GTP γS (10-8-10-4 M) in the presence of Na+ (100 mM) reduced binding in a dose-dependent manner, whereas GMP was ineffective. In conclusion, β-endorphin binds to sites on human U937 cells similar to those observed on normal murine spleno-cytes. Although naloxone insensitive, these sites exhibit properties, such as size, salt sensitivity, and coupling to a GTP-binding protein, that are similar to those observed for agonist binding to brain opiate receptors.

AB - Some of the functional effects of β-endorphin on immune cells are resistant to inhibition by naloxone. To further characterize the β-[125I]endorphin-binding site mediating these effects and its response to cations and GTP, the human monocyte-like cell line U937 was used. Incubation of intact cells and -β-[125I]endorphin for 60 min at 4 C demonstrated a saturable, high affinity binding site [Kd = 1.2 ± 0.5 x 10-8 M (mean ± SE; n = 4] competed by equimolar β-endorphin and N-acetyl (Ac)-β-endorphin but not by naloxone, morphine, or selective opiate receptor agonists. Competition studies showed that β-endorphin-(6-31) and β-endorphin-(28-31) were approximately 5-and 100fold less potent, respectively, whereas β-endorphin-(l-16) or -(1-27) was ineffective. Covalent cross-linking of β-[125I]endorphin to intact cells and resolution by gel electrophoresis showed dominant bands at 59K and 44K and a minor band at 66K. The bands at 44K and 66K were completely displaced by increasing equivalent concentrations of β-endorphin and N-Ac-β-endor-phin. Increasing concentrations of mono (Na+K+)-and divalent (Ca2+Mg2+Mn2+) cations reduced the binding of β-[125I]endorphin to U937 membrane; β-[125I] endorphin binding to rat brain membrane showed similar cation sensitivity. GTP7-sulfate (GTPγS; 10-4 M) alone reduced binding to U937 membrane by 25%. In the presence of Na+ (100 or 150 mM) or Mg2+ (10 mM), GTP γS reduced binding by an additional 50%. Moreover, GTP γS (10-8-10-4 M) in the presence of Na+ (100 mM) reduced binding in a dose-dependent manner, whereas GMP was ineffective. In conclusion, β-endorphin binds to sites on human U937 cells similar to those observed on normal murine spleno-cytes. Although naloxone insensitive, these sites exhibit properties, such as size, salt sensitivity, and coupling to a GTP-binding protein, that are similar to those observed for agonist binding to brain opiate receptors.

UR - http://www.scopus.com/inward/record.url?scp=0025285730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025285730&partnerID=8YFLogxK

U2 - 10.1210/endo-126-6-3006

DO - 10.1210/endo-126-6-3006

M3 - Article

VL - 126

SP - 3006

EP - 3015

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -